Keybanc analyst Paul Knight maintains Thermo Fisher Scientific (NYSE:TMO) with a Overweight and lowers the price target from $710 to $640.
Keybanc analyst Paul Knight maintains Thermo Fisher Scientific (NYSE:TMO) with a Overweight and lowers the price target from $710 to $640.